Search  Follow Investorideas on Twitter  Investorideas is on Facebook  Investorideas is on Google Plus  Investorideas is on Youtube  Investorideas is on Pinterest  Investorideas is on tumblr  Investorideas is on LinkedIn  Investorideas RSS 

Investorideas podcasts on iTunes, Google Play Music and    Bitcoin and Blockchain Stocks    Play by Play – the latest sports headlines and sports stock news


Join Investor Ideas Members to access the Renewable Energy stocks directory, water stocks, biotech stocks, defense stocks directories and the Insiders Corner

Exoskeleton Investment in Military Applications Drives Tenfold Market Growth by 2022

Global military spend on exoskeletons to grow by 119.5% annually


Hampshire, UK - June 7, 2017 ( Newswire) A new report from Juniper Research forecasts that revenues from exoskeleton rental and sales will increase from just $53m in 2017 to $559m by 2022, a y-o-y growth of over 900%.

The research found that despite compelling new applications in healthcare and workplace settings, military will continue to dominate exoskeleton deployments over the next 5 years.

Military as the Growth Engine

The new research, Exoskeletons - Medical, Industrial & Military: Market Opportunities & Forecasts 2017-2022, highlights that military exoskeletons will make up over 80% of exoskeleton shipments by 2022. It found that in the short to medium term, unpowered exoskeletons such as the Marine Mojo developed by 20KTS+, will make up the majority of deployments.

Powered exoskeletons, the focus of much attention for this industry, will be initially restricted to naval deployments, where power supplies are more readily available than for other armed forces. The research notes that the arrival of advanced powered exoskeletons in other contexts is still several years away.

"By 2019, we should see more sophisticated military exoskeletons being tested and deployed," said report author James Moar. "Although these will account for a small percentage of deployments, this - and more widespread implementation of mid-range models such as the Lockheed SKD - will see a dramatic uplift in average pricing, resulting in a sharp rise in the overall value of the market."

Making the Case for Industrial & Medical Exoskeletons

In addition, the research argued that other industries need to make a business case for deploying exoskeletons to accelerate adoption. In some industries, like construction, this is relatively simple, as their value can be quantified through the savings made in time, productivity and work safety.

In other contexts, such as healthcare or manufacturing, exoskeletons still need to demonstrate an effective return-on-investment, particularly when alternatives (such as cheaper, longer-term treatments or full automation) are available.

The whitepaper, Top 3 Exoskeleton Market Trends & What They Mean, is available to download from the Juniper Research website together with further details of the new research.

Juniper Research provides research and analytical services to the global hi-tech communications sector, providing consultancy, analyst reports and industry commentary.

Contact: - investing ideas for Defense stocks, Biometrics stocks, Homeland security stocks, Biodefense stocks, Cyber security stocks

Like Defense and Security Stocks? View our Defense and Security Stocks Directory

Get News Alerts on Defense Stocks

More Info: Newswire

This news is published on the Newswire - a global digital news source for investors and business leaders

Disclaimer/Disclosure: is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: Learn more about publishing your news release on the newswire

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: Global investors must adhere to regulations of each country.